Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rennie Deflatine chewable tablets
010102100BBABAB
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 303 |
|
Rennie Peppermint chewable tablets
010102100BBAQAF
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 298 |
|
Rennie Spearmint chewable tablets
010102100BBARAF
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 75 |
|
Pepto-Bismol 262.5mg chewable tablets
010102100BBBDAI
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 41 |
|
Rennie Ice chewable tablets
010102100BBBCAF
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 12 |
|
Rennie Extra chewable tablets
010102100BBAZA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 7 |
|
Pepto-Bismol 17.5mg/1ml oral suspension
010102100BBAWAG
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 3 |
|
Rennie Sugar Free chewable tablets
010102100BBBAAH
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 1 |
|
Bisodol Extra Strong Mint chewable tablets
010102100BBAYA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Bisodol Indigestion Relief chewable tablets
010102100BBAMA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Bisodol Indigestion Relief oral powder
010102100BBANA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Bisodol Wind Relief tablets
010102100BBAJA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Boots Indigestion Relief chewable tablets original
010102100BBAFA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Boots Indigestion Relief chewable tablets peppermint
010102100BBAUA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Boots Pepti-Calm 525.6mg/30ml oral suspension
010102100BBBFAG
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Carbellon tablets
010102100BBADA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Eno effervescent powder
010102100BBASA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Eno effervescent powder 5g sachets
010102100BBATA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Galpharm 3-In-1 Antacid chewable tablets
010102100BBAXA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Indian Brandee oral liquid
010102100BBBEA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Pepcidtwo chewable tablets
010102100BBAKA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Rennie Heartburn, Indigestion and Wind Relief chewable tab
010102100BBBGAB
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.